Literature DB >> 11568017

Presence of N regions in the clonotypic DJ rearrangements of the immunoglobulin heavy-chain genes indicates an exquisitely short latency in t(4;11)-positive infant acute lymphoblastic leukemia.

K Fasching1, S Panzer, O A Haas, A Borkhardt, R Marschalek, F Griesinger, E R Panzer-Grümayer.   

Abstract

Childhood acute lymphoblastic leukemia (ALL) is frequently initiated in utero at a time of developmentally regulated insertion of N regions into the DJ(H) rearrangements of immunoglobulin heavy-chain (Ig(H)) genes. Here it is shown that N regions are present in the clonotypic DJ(H) rearrangements in 11 of 12 infant ALLs with t(4;11). These data are compared with the 122 previously published DJ(H) sequences and were found to have a pattern similar to that of ALL in children older than 3 years at diagnosis but were unlike that in children younger than 3 years who predominantly lack N regions. These findings, therefore, indicate that t(4;11)-positive infant ALL is initiated later in fetal development than most B-cell precursor ALL from children younger than 3 years and that they have a shorter latency period already in utero.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11568017     DOI: 10.1182/blood.v98.7.2272

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia.

Authors:  Joseph L Wiemels; Brian C Leonard; Yunxia Wang; Mark R Segal; Stephen P Hunger; Martyn T Smith; Vonda Crouse; Xiaomei Ma; Patricia A Buffler; Sharon R Pine
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

Review 2.  Perspectives on the causes of childhood leukemia.

Authors:  Joseph Wiemels
Journal:  Chem Biol Interact       Date:  2012-02-02       Impact factor: 5.192

3.  Prenatal origin of childhood AML occurs less frequently than in childhood ALL.

Authors:  Tatiana Burjanivova; Jozef Madzo; Katerina Muzikova; Claus Meyer; Bjoern Schneider; Felix Votava; Rolf Marschalek; Jan Stary; Jan Trka; Jan Zuna
Journal:  BMC Cancer       Date:  2006-04-21       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.